Evaluation of the Implementation of the UK Antimicrobial Resistance (AMR) Strategy, 2013-2018

  29 April 2020

The aims of the Strategy were to be achieved through activity in seven areas: improving infection prevention and control; optimising prescribing practice; improving professional education, training and public engagement; developing new drugs, treatments and diagnostics; better access to and use of surveillance data; better identification and prioritisation of research needs; and strengthened international
collaboration. The Strategy was developed within a One Health approach,2 thus the scope of the Strategy included issues relevant to human health, animal health and husbandry, agriculture, and the wider environment.

Author(s): Policy Innovation and Evaluation Research Unit
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed